Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who signed an informed consent form~* Patients who underwent resection or biopsy for GBM~* KPS\> 70~Exclusion Criteria:~* Patients being treated with antidepressants~* Unable to answer the questionnaires because of an inability to communicate~* Patients being treated; monoamine oxidase inhibitors (MAOI) CYP1A2 Inhibitors or (CYP2D6 inhibitors (SSRIs such as fluoxetine, paroxetine, or anti-arrhythmia such as quinidine) Patients with Glaucoma, narrow angle~* Severe renal dysfunction. According to laboratory criteria specified earlier.~* Hepatic insufficiency - which laboratory criteria mentioned earlier.~* Pregnant women Patients Dementia~* Patients who previously suffered from depression in the past or within 5 years of diagnosis, and currently do not receive drug therapy~* Sensitivity to any of its ingredients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Group # 1- ACTIVE (Type: ACTIVE_COMPARATOR): Patients who underwent resection or biopsy of glioblastoma (newly diagnosed glioblastoma), will randomization ratio of 1: 1 by the pharmacist (by age, KPS, the degree of tumor resection) two research groups:~Group # 1: consisting of 50 patients who will be treated immediately after diagnosis, 30 mg Cymbalta duloxetine -morning for a week and then a dose exceeding 60 mg for 3 months.
- Group # 2-PLACEBO (Type: PLACEBO_COMPARATOR): Group # 2 will include 50 patients treated immediately after diagnosis with placebo for 3 months

Based on this trial design, predict the completion outcome and termination type (if applicable).